Purchase Order HHSN312201700005P

<p>The NIH Clinical Center issued a purchase order to Standard Biotools Inc. (doing business as Fluidigm) on July 9, 2019, valued at $16,925.30. Work is performed at Standard Biotools' South San Francisco, California facility. This is a firm fixed price purchase order for advanced scientific instruments and consumables. The order completion date is August 8, 2019.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Standard Biotools Inc. (doing business as Fluidigm) for $19,158.00 on September 17, 2018, with ultimate completion on September 16, 2019. The order covers a BioMark HD Standard Service Plan on a firm fixed price basis. Performance occurs at Standard Biotools' facility in South San Francisco, California.</p>

<p>The National Institute of Child Health and Human Development awarded a purchase order to Standard Biotools Inc. (doing business as Fluidigm) on August 2, 2018, with a ceiling value of $16,020.00 and a firm fixed price structure. Place of performance is South San Francisco, California. The order is set for ultimate completion on September 13, 2019. No set-aside category applies to this acquisition.</p>

<p>The National Institute of Child Health and Human Development awarded a purchase order to Standard Biotools Inc. (doing business as Fluidigm) on May 29, 2019, with a ceiling value of $14,899.00 for firm fixed price procurement of scientific instruments or consumables. Place of performance is South San Francisco, California. The order was completed by September 13, 2020. No small business set-aside was used.</p>

<p>The National Cancer Institute awarded a purchase order to Standard Biotools Inc. (doing business as Fluidigm) on September 7, 2017, with a ceiling value of $6,088.50. The order carries no set-aside designation. Place of performance is Bethesda, Maryland. The ultimate completion date is October 9, 2017. Pricing is firm fixed price. The specific requirements are not detailed in the source material.</p>

<p>The National Institute of Nursing Research awarded a purchase order to Illumina, Inc. for $13,512.96 on April 2, 2018, with completion scheduled for May 2, 2018. Work is performed in San Diego, California. The order is firm fixed price with no set-aside category applied. The source does not specify the particular equipment, reagents, consumables, or services procured under this order.</p>

The Department of Health and Human Services National Institutes of Health National Institute of Environmental Health Sciences awarded a $13,911.60 firm-fixed price purchase order to Standard Biotools Inc., doing business as Fluidigm, for invoice and payment provisions. The award does not have a set-aside designation. Fluidigm is a manufacturer of scientific products and instruments that has provided a variety of goods and services to U.S. federal agencies through both prime and sub-contracts...

<p>The National Cancer Institute awarded a purchase order to Standard Biotools Inc. (doing business as Fluidigm) for biological and reagent material valued at $13,690.00 on March 5, 2021, with completion scheduled for July 7, 2021. No set-aside was applied. Performance takes place in South San Francisco, California. The order is a firm fixed-price procurement for direct-use biological and reagent materials.</p>

<p>The National Cancer Institute awarded a purchase order to Standard Biotools Inc., doing business as Fluidigm, valued at $16,020.00, on May 7, 2018. No set-aside category was used. Place of performance is Bethesda, Maryland. The order has an ultimate completion date of July 10, 2019 and carries firm fixed pricing.</p>

<p>The National Heart Lung and Blood Institute issued a purchase order to Standard Biotools Inc. (doing business as Fluidigm) on May 7, 2018, for $40,676.00 to procure Fluidigm chips enabling analysis of 96 different RNAs from 96 individual cells. Performance occurs at Bethesda, Maryland. The order carries a firm fixed price and completes by June 8, 2018.</p>